Clinical trial
Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults
NCT00187148 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00187148 |
|---|---|
| Title | Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults |
| Official title | Evaluation of the Tolerability and Safety of a Recombinant HIV-1 Multi-Envelope DNA Plasmid Vaccine (EnvDNA) in Healthy Adults |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Human Immunodeficiency Virus, HIV Infections |
| Intervention type | Biological |
| Interventions | EnvDNA |
| Enrollment | 6 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: